Reminder: Welcome to Elekta’s Capital Markets Presentation at ASTRO
The event will be held on Monday, October 19, at 09:00–11:30 am, at Marriott Riverwalk.
Speakers at the event will be Tomas Puusepp, Elekta’s President and CEO, and other members of Elekta’s management team.
To attend, please register via http://www.cvent.com/d/xrqt5h/1Q.
It will also be possible to listen in to the Capital Markets Presentation via the web. Please note that we only will be able to take questions from the participants on location in San Antonio. Details will be published on Elekta's webpage (www.elekta.com/investors) prior to the meeting.
We look forward to your participation on October 19, 2015.
Director Investor Relations
Director Financial Communication
Investor Relations Coordinator
# # #
For further information, please contact:
Frida Johansson, Investor Relations Coordinator, Elekta AB (publ)
Tel: +46 70 866 76 74, e-mail: Frida.Johansson@elekta.com
Time zone: CET: Central European Time
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.